JDD June 2023 Issue Highlights
176051760517605
The June issue of the Journal of Drugs in Dermatology (JDD) features original articles with topics ranging from pediatric acne, rosacea, androgenetic alopecia, precision medicine, infantile hemangiomas, and many more. Check out this month’s issue highlights straight from the JDD Editor’s desk:
The Many Faces of Pediatric Acne: A Practical Algorithm for Treatment, Maintenance Therapy, and …
The June issue of the Journal of Drugs in Dermatology (JDD) features original articles with topics ranging from pediatric acne, rosacea, androgenetic alopecia, precision medicine, infantile hemangiomas, and many more. Check out this month’s issue highlights straight from the JDD Editor’s desk:
The Many Faces of Pediatric Acne: A Practical Algorithm for Treatment, Maintenance Therapy, and … 
A 13-year-old girl is brought to the office because she has had the pruritic rash shown for the past 11 months. Her parents say none of the small tubes of moisturizers provided relief, including hydrocortisone 1%, which they applied for 4 days with minimal improvement. Daily bathing and petrolatum application are performed at home. Her medical history is unremarkable except for a peanut allergy, … 
A 15-year-old girl comes to the clinic with her mother for dry, itchy skin that waxes and wanes for years. The patient states it worsens in the dry winter, along with during times of stress and anxiety. Examination reveals the findings pictured. What is the function of the gene product most commonly mutated in for this condition?
A. Initiate and maintain intercellular adhesion of keratinocy … 
A 55-year-old patient from the Caribbean presents with indurated scaly papules and plaques on his trunk, arms, and legs. The rash started six months ago and has progressed rather quickly. Review of system was notable for pruritus and xerosis; patient reported no personal history of skin diseases, including psoriasis and atopic dermatitis. Several 4-mm punch biopsies were performed. Based on th … 
Apremilast (OTEZLA®) is a twice daily oral medication that is FDA approved for adults with plaque psoriasis, psoriatic arthritis and oral ulcers associated with Behçet’s Disease.1 This drug is being extended as an off-label treatment to target inflammation in a number of different conditions. This Therapeutic Cheat Sheet will focus on apremilast and its applications for different dermatologica … 